You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Moodys
Baxter
Express Scripts
McKinsey

Last Updated: March 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Shire ViroPharma Incorporated v. CSL Behring LLC (D. Del. 2017)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Shire ViroPharma Incorporated v. CSL Behring LLC (D. Del. 2017)

Docket   Start Trial Date Filed 2017-04-11
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Mitchell S. Goldberg
Jury Demand Plaintiff Referred To
Parties CSL BEHRING GMBH; CSL BEHRING LLC; SHIRE VIROPHARMA INCORPORATED
Patents 10,080,788; 10,201,595
Attorneys Amanda K. Murphy; Anita Spieth; Daniel C. Winston; David M. Fry; Derek James Fahnestock; Eric J. Marandett; Jonathan R. Davies; Karen Elizabeth Keller; Karen Jacobs; Lillian M. Robinson; Nathan Roger Hoeschen; Ryan P. O'Quinn; Sanya Sukduang
Firms Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Biologic Drugs cited in Shire ViroPharma Incorporated v. CSL Behring LLC
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Shire ViroPharma Incorporated v. CSL Behring LLC (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 140 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,616,111 ;10,080,788 ;10,105,423 ;… 11 April 2017 1:17-cv-00414 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 162 Notice of Service Intrinsic Evidence for Identified Terms of U.S. Patent Nos. 10,080,788, 10,105,423, 10,130,690 and 10,201,595 … 11 April 2017 1:17-cv-00414 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 190 Answer to Complaint First Amended Counterclaims Concerning U.S. Patent Nos. 10,080,788; 10,105,432; 10,130,690; and 10,201,595… 11 April 2017 1:17-cv-00414 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 201 Redacted Document First Amended Counterclaims Concerning U.S. Patent Nos. 10,080,788; 10,105,432; 10,130,690; and 10,201,595… 11 April 2017 1:17-cv-00414 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 216 Opinion - Memorandum Opinion that a fourth continuation patent—Patent No. 10,201,595 (the “’595 Patent”)—would issue on February …more claims of Shire’s ’788 Patent, ’423 Patent, ’690 Patent, and ’595 Patent. (Id. ¶¶ 32– 100.) …at least claim 1 of the ’788 Patent, the ’423 Patent, and the ’690 Patent. The PTO then indicated that…¶¶ 14–19.) B. The Patents-in-Suit 1. The ’788 Patent On September 25, 2018…2018, the United States Patent and Trademark Office (“PTO”) issued the ’788 Patent, entitled “C1-INH Compositions External link to document
2019-11-18 237 Opinion - Memorandum Opinion additional patents—U.S. Patent Nos. 10,080,788 (the “’788 patent”), 10,105,423 (the “’423 patent”), 10,130690… . . .” (’788 patent, claim 1; ’595 patent, claim 1; ’423 patent, claim 1, ’690 patent, claim 1.) Notably… least claim 1 of the ’788 patent, the ’423 patent, and the ’690 patent. The PTO then indicated that…multiple patents owned by Plaintiff. Plaintiff originally alleged infringement of U.S. Patent No. 9,616,111…,130690 (the “’690 patent”), and 10,201,595 (the “’595” patent)—which share the same specification as External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
McKinsey
Johnson and Johnson
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.